Theresa Nguyen, DPM
Primary Podiatric Medicine · Plano, TXNPI 1487959219
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,018 and has fallen 59.0% since, to $417 in 2025.
Across 101 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$417
- Amgen$306
- Smith+Nephew$206
- Stryker$140
- Sanofi$122
- ANI Pharmaceuticals, Inc.$105
- plus $891 from 21 others
What the payments were for
- Food & beverage$2,187100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 28 | $417 |
| Amgen(2 entities) | 18 | $306 |
| Smith+Nephew | 8 | $206 |
| Stryker | 2 | $140 |
| Sanofi | 1 | $122 |
| ANI Pharmaceuticals, Inc. | 5 | $105 |
| Novo Nordisk | 1 | $99 |
| AbbVie | 6 | $95 |
| Organogenesis Inc. | 4 | $88 |
| Averitas Pharma Inc. | 3 | $87 |
| Johnson & Johnson | 2 | $77 |
| Mimedx Group, Inc. | 3 | $69 |
| Innovation Technologies Inc | 2 | $48 |
| Melinta Therapeutics, LLC | 3 | $41 |
| Convatec Inc. | 1 | $34 |
| IBSA Pharma Inc. | 2 | $30 |
| Reddress USA, Inc. | 1 | $27 |
| Nuo Therapeutics | 2 | $26 |
| Reprise Biomedical, Inc. | 1 | $24 |
| Kerecis Limited | 1 | $23 |
| KCI USA, Inc. | 1 | $20 |
| Molnlycke Health Care US, LLC | 1 | $20 |
| Pylant Medical | 1 | $19 |
| Cashflow Solutions, LLC | 1 | $19 |
| Urgo Medical North America, LLC | 1 | $18 |
| Celularity Inc. | 1 | $14 |
| Nevro Corp. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FABRAZYME$122
How this compares
$2,187 in reported general payments places this provider in the 55th percentile of 36 primary podiatric medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 17 | $562 |
| Ciprofloxacin Hcl | 14 | $171 |
| Doxycycline Hyclate | 13 | $116 |
| Methylprednisolone | 14 | $114 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Plano
- Kenneth WilliamsSan Antonio$26K
- Tomas TrevinoEl Campo$17K
- Irene ArroyoDallas$11K
- Fernando FernandezThe Woodlands$7K
- Susie Sant'annaFredericksburg$7K
- Silas SalanoArlington$6K
- Christian MorrisonMurphy$6K
- Barton GarciaShenandoah$5K
- Eric HigginsDumas$3K
- Maureen CaldwellVictoria$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.